Itasca Capital Ltd. (ICL)

Itasca Capital Ltd. (ICL)
- Fwd P/E: -36.9X Cap: $44M
- View ICL Profile
- View Questions on ICL

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Itasca Capital Ltd. (ICL)
- Fwd P/E: -36.9X Cap: $44M
- View ICL Profile
- View Questions on ICL

Q: Hello,

My value screen surfaced Israel Chemicals Ltd. recently. It has quite decent fundamentals.

So how does an NYSE-traded company with $6B (2018) in revenue and a market cap of $18B that is a significant miner of bromine and potash and exporter of fertilizers ... not have any North American analysts following it as far as I can tell, and seemingly low trading volumes? Is it because it is based in Israel and also trades there?

I'd appreciate hearing your perspective. Thanks as always!

Read Answer Asked by Marc on February 10, 2020